The treatment with PIO was capable of improving this IR and reduced PH, by reversing the decreased expression of adiponectin and PPARg, highlighting the mechanisms involved in PAH patients with IR in obesity, and the potential use of PIO as a treatment (18). This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.